FindTrial
Sign In

A Multicenter, Observational Study Inverstigating the Distribution of Concomitant Medications and Predicted Drug-Durg Interactions with Direct-Acting Antiviral Agents in Chinese Patients with Chronic Hepatitis C Virus Genptype 1 Infections

A Multicenter, Observational Study Inverstigating the Distribution of Concomitant Medications and Predicted Drug-Durg Interactions with Direct-Acting Antiviral Agents in Chinese Patients with Chronic Hepatitis C Virus Genptype 1 Infections

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032526
Enrollment
Unknown
Registered
2020-05-01
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis C Virus Genptype 1 Infections

Interventions

case series:N/A

Sponsors

Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old at the time of signing the informed consent; 2. Patients with HCV genotype 1 infection; 3. For patients with the initial DAA treatment plan; 4. Patients willing to participate in the study and sign informed consent before study screening.

Exclusion criteria

Exclusion criteria: 1. Patients of non Chinese origin; 2. At the discretion of the investigator, patients with confounding or other potential causes affecting the completion of the study procedure.

Design outcomes

Primary

MeasureTime frame
Concomitant medication;DAA;CHC clinical features;—

Secondary

MeasureTime frame
demographic;Medical history;—

Countries

China

Contacts

Public ContactJuan Wang

West China Hospital of Sichuan University

4082608@qq.com+86 18010530928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026